STTK Stock Analysis: Buy, Sell, or Hold?
STTK - Shattuck Labs, Inc. Common Stock
$7.05
0.54 (8.29%)
▲
5d:
+19.29%
30d:
+44.76%
90d:
+12.8%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When STTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: STTK is 14.1% above its trading range ($6.18). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: STTK is 14.1% above its trading range ($6.18). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: STTK is currently trading at $7.05, which is considered extended relative to its 30-day fair value range of $4.44 to $6.18.
Technical Outlook: Technically, STTK is in a downtrend. Immediate support is located at $4.73, while resistance sits at $7.41. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: STTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.83 (+110.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STTK is in a downtrend. Immediate support is located at $4.73, while resistance sits at $7.41. The stock is showing strong short-term momentum, up 8.3% recently.
Market Sentiment: STTK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.83 (+110.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.44 -
$6.18
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+14.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.3%)
- BULLISH: Trading 110.4% below Wall St target ($14.83)
Trading Range Analysis
30-Day Trading Range
$4.44 -
$6.18
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.73
Resistance Level
$7.41
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.67
Wall Street Target
$14.83
(+110.4%)
Revenue Growth (YoY)
-66.6%
Share & Embed Analysis
Last updated: July 03, 2026 3:54 PM ET
Data refreshes hourly during market hours. Next update: 4:54 PM
Data refreshes hourly during market hours. Next update: 4:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 45 HOLD |
